Akum Drugs & Pharmaceutical gets CDSCO Panel nod for BE study of FDC Eplerenone plus Torsemide film-coated tablet Dr. Divya Colin8 Dec 2024 5:45 PM ISTNew Delhi: Akum Drugs and Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Synokem gets CDSCO Panel nod to study FDC Torsemide plus Eplerenone film coated tablet Dr. Divya Colin6 Feb 2024 6:00 PM ISTNew Delhi: Considering the bioequivalence (BE) report of the fixed-dose combination (FDC) Torsemide IP 10mg/ 20mg plus Eplerenone IP 25mg/25mg...
Conduct BE study with innovator drug as reference product: CDSCO Panel Tells Synokem on FDC Torsemide plus Eplerenone Dr. Divya Colin30 Dec 2023 5:45 PM ISTNew Delhi: After reviewing the bioequivalence (BE) study report presented by Synokem Pharmaceutical for the fixed-dose combination Torsemide IP...
Use of Eplerenone potential strategy to reduce arterial inflammation among persons with HIV: JAMA Medha Baranwal22 Dec 2023 10:00 AM ISTUSA: Eplerenone was shown to significantly reduce arterial inflammation in a 12-month, placebo-controlled, randomized clinical trial of 26...
Eplerenone improves clinical stability in patients hospitalized with acute heart failure: Study Medha Baranwal5 Jan 2023 9:30 AM ISTJapan: Treatment with eplerenone improves clinical stability, especially during the short period after hospitalization for acute HF (AHF); this is the...
Mineralocorticoid Receptor Antagonists offer great economic value in HF patients: AHA/ACC/HFSA 2022. Dr. Prem Aggarwal28 April 2022 12:45 PM ISTMineralocorticoid Receptor Antagonists (MRA) have a great potential economic value to offer in patients with Heart Failure with mild ejection fraction...
Eplerenone reduces urinary Albumin creatinine ratio in diabetics at high risk of CVD: Study Dr. Shravani Dali18 Oct 2021 9:00 AM ISTEplerenone improves Albumin Excretion in type 2 diabetes (T2D) With Acceptable Safety, suggests a study published in the Diabetes and Metabolism.As...
High-dose eplerenone reduces urinary albumin creatinine ratio in Diabetes: Study Dr Kartikeya Kohli18 Dec 2020 2:15 PM ISTResearchers of Copenhagen University Hospital have found, Add on therapy of high dose eplerenone to T2D patients with a high risk of cardiovascular...
Eplerenone not beneficial for treatment of central serous chorioretinopathy: Lancet Medha Baranwal18 Feb 2020 5:30 PM ISTUK: Eplerenone, a drug widely used for the treatment of central serous chorioretinopathy (CSCR), is not beneficial and should no longer be used, a...
